The right diagnosis,
right away,
at the right price.

We are the creators of Genomtec ID, a mobile platform for genetic diagnostics at the point of patient care. We have just obtained our CE-IVD Mark for the GenomtecID Respiratory Panel 5-Plex (RP5-PLEX) which detects viruses and bacteria causing respiratory tract infections, the only solution of this kind in Europe. See more >>

News

2025.07.31

Genomtec’s Supervisory Board appointed Leroy Huntley to the Company’s Management Board

Genomtec S.A. announced the appointment of Mr. Leroy Huntley to the Company’s Management Board on July 30, 2025, with effect from August 1, 2025. Leroy Huntley serves as Chief Technology Officer (CTO) at Genomtec and has been associated with the Company since 2022. His appointment strengthens the Management Board’s competences at a key moment for […]

2025.07.14

Genomtec has the consent of its shareholders to make a contribution of assets to its subsidiaries in order to accelerate the project sale process

At the Extraordinary General Meeting of Genomtec SA on July 11, 2025, the Shareholders adopted resolutions on the contribution in kind of tangible and intangible assets related to the Genomtec ID platform and the OncoSNAAT project to the special purpose vehicles GMT ID SA and GMT GENOMICS SA, respectively, in which Genomtec SA holds 100% […]

2025.03.26

Genomtec implements changes in organizational structure to accelerate M&A process

Genomtec SA has established two special purpose vehicles, GMT ID SA and GMT Genomics SA, in which it holds 100% of the shares. They will receive tangible and intangible assets related to the Genomtec ID platform and the OncoSNAAT project, respectively. Each special purpose vehicle, dedicated to a separate technology segment, can be offered separately […]

Awards